Medipharm Labs Corp T.LABS

Alternate Symbol(s): MEDIF

Healthcare Cannabis

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.

TSX:LABS - Post by User

Medipharm Labs Corp

<< Previous

Bullboard Posts

Next >>

Post by 1hot-techwomanon Aug 13, 2021 10:55am

147 Views

Post# 33700494

Q2 coming Mon Aug 16th ! Buying more at 52 week low :)

MediPharm Labs Sets Date to Report Second Quarter 2021 Financial Results

Tuesday, August 10, 2021, 7:00 AM ET

MediPharm Labs Sets Date to Report Second Quarter 2021 Financial Results

TORONTO, Aug. 10, 2021 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) ("MediPharm Labs" or the "Company") a pharmaceutical company specialized in research-driven development and manufacturing of cannabis API and finished products, is pleased to announce it will release second quarter financial results for the three and six month period ended June 30, 2021 before markets open on Monday, August 16, 2021.

<< Previous

Bullboard Posts

Next >>

Junior helium miner will explore record discovery in Q4